Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S
Sci Rep. 2024; 14(1):3993.
PMID: 38368446
PMC: 10874434.
DOI: 10.1038/s41598-024-54728-z.
Noorbakhsh N, Hayatmoghadam B, Jamali M, Golmohammadi M, Kavianpour M
Cancer Cell Int. 2021; 21(1):705.
PMID: 34953494
PMC: 8710012.
DOI: 10.1186/s12935-021-02408-7.
Luo J, Xiang H
Bioengineered. 2021; 12(1):3101-3112.
PMID: 34181498
PMC: 8806516.
DOI: 10.1080/21655979.2021.1944019.
Allegra A, Pioggia G, Innao V, Musolino C, Gangemi S
Cancers (Basel). 2021; 13(8).
PMID: 33924049
PMC: 8073623.
DOI: 10.3390/cancers13081981.
Aguirre-Ruiz P, Ariceta B, Cruz Viguria M, Zudaire M, Blasco-Iturri Z, Arnedo P
J Clin Med. 2020; 9(12).
PMID: 33255857
PMC: 7760908.
DOI: 10.3390/jcm9123818.
miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway.
Hu C, Yu M, Li C, Wang Y, Li X, Ulrich B
Int J Biol Sci. 2020; 16(15):2853-2867.
PMID: 33061801
PMC: 7545716.
DOI: 10.7150/ijbs.44365.
LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie S, Zhang J, Jiang X, Hua Y, Xie S, Qin Y
Cell Death Dis. 2020; 11(8):676.
PMID: 32826865
PMC: 7442829.
DOI: 10.1038/s41419-020-02853-8.
Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
Zhao C, Zeng C, Ye S, Dai X, He Q, Yang B
Acta Pharm Sin B. 2020; 10(6):947-960.
PMID: 32642404
PMC: 7332664.
DOI: 10.1016/j.apsb.2019.12.010.
Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia.
Aberuyi N, Rahgozar S, Ghodousi E, Ghaedi K
Front Oncol. 2020; 9:1496.
PMID: 32010613
PMC: 6978753.
DOI: 10.3389/fonc.2019.01496.
Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ.
Geng Z, Wang W, Chen H, Mao J, Li Z, Zhou J
Cell Biosci. 2020; 9:104.
PMID: 31893023
PMC: 6937801.
DOI: 10.1186/s13578-019-0359-y.
Lactate-fueled oxidative metabolism drives DNA methyltransferase 1-mediated transcriptional co-activator with PDZ binding domain protein activation.
Huang T, Zhou X, Mao X, Yu C, Zhang Z, Yang J
Cancer Sci. 2019; 111(1):186-199.
PMID: 31746077
PMC: 6942427.
DOI: 10.1111/cas.14246.
TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC.
Grieve S, Wajnberg G, Lees M, Chacko S, Weir J, Crapoulet N
Blood Adv. 2019; 3(22):3613-3625.
PMID: 31743393
PMC: 6880893.
DOI: 10.1182/bloodadvances.2019000374.
Outcome in serous ovarian cancer is not associated with LATS expression.
Montavon C, Stricker G, Schoetzau A, Heinzelmann-Schwarz V, Jacob F, Fedier A
J Cancer Res Clin Oncol. 2019; 145(11):2737-2749.
PMID: 31586262
PMC: 6800864.
DOI: 10.1007/s00432-019-03037-4.
Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.
Dawidowska M, Jaksik R, Drobna M, Szarzynska-Zawadzka B, Kosmalska M, Sedek L
Neoplasia. 2019; 21(3):294-310.
PMID: 30763910
PMC: 6372882.
DOI: 10.1016/j.neo.2019.01.004.
Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell.
Wu R, Yang H, Wan J, Deng X, Chen L, Hao S
Mol Med Rep. 2018; 18(6):5379-5388.
PMID: 30320399
PMC: 6236312.
DOI: 10.3892/mmr.2018.9556.
promoter hypermethylation and its effect on gene expression in human breast cancer.
Matsui S, Kagara N, Mishima C, Naoi Y, Shimoda M, Shimomura A
Oncol Lett. 2018; 15(2):2595-2603.
PMID: 29434979
PMC: 5777308.
DOI: 10.3892/ol.2017.7535.
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.
Zhang S, Wang J, Wang H, Fan L, Fan B, Zeng B
Am J Pathol. 2018; 188(4):995-1006.
PMID: 29378174
PMC: 5866106.
DOI: 10.1016/j.ajpath.2017.12.017.
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
Furth N, Aylon Y
Cell Death Differ. 2017; 24(9):1488-1501.
PMID: 28644436
PMC: 5563998.
DOI: 10.1038/cdd.2017.99.
Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
Malik S, Khan M, Dar M, Hussain M, Shah M, Shafi S
Pathol Oncol Res. 2017; 24(2):207-214.
PMID: 28434174
DOI: 10.1007/s12253-017-0225-3.
YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid.
Xu G, Wang J, Wu F, Wang N, Zhou W, Wang Q
Oncotarget. 2016; 7(32):52150-52165.
PMID: 27437776
PMC: 5239541.
DOI: 10.18632/oncotarget.10663.
